HEADER TRANSFERASE 08-AUG-17 5OOT TITLE STRUCTURE OF CHK1 10-PT. MUTANT COMPLEX WITH AMINOPYRIMIDO- TITLE 2 BENZODIAZEPINONE LRRK2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE CHK1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CHK1 CHECKPOINT HOMOLOG,CELL CYCLE CHECKPOINT KINASE, COMPND 5 CHECKPOINT KINASE-1; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CHEK1, CHK1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PFASTBAC1 KEYWDS PARKINSON'S DISEASE, LEUCINE-RICH REPEAT KINASE 2, LRRK2, CHECKPOINT KEYWDS 2 KINASE 1, CHK1, MUTANT, SURROGATE, KINASE INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR P.DOKURNO,D.S.WILLIAMSON,P.ACHESON-DOSSANG,I.CHEN,J.B.MURRAY,T.SHAW, AUTHOR 2 A.E.SURGENOR REVDAT 3 17-JAN-24 5OOT 1 REMARK REVDAT 2 22-NOV-17 5OOT 1 JRNL REVDAT 1 25-OCT-17 5OOT 0 JRNL AUTH D.S.WILLIAMSON,G.P.SMITH,P.ACHESON-DOSSANG,S.T.BEDFORD, JRNL AUTH 2 V.CHELL,I.J.CHEN,J.C.A.DAECHSEL,Z.DANIELS,L.DAVID,P.DOKURNO, JRNL AUTH 3 M.HENTZER,M.C.HERZIG,R.E.HUBBARD,J.D.MOORE,J.B.MURRAY, JRNL AUTH 4 S.NEWLAND,S.C.RAY,T.SHAW,A.E.SURGENOR,L.TERRY,K.THIRSTRUP, JRNL AUTH 5 Y.WANG,K.V.CHRISTENSEN JRNL TITL DESIGN OF LEUCINE-RICH REPEAT KINASE 2 (LRRK2) INHIBITORS JRNL TITL 2 USING A CRYSTALLOGRAPHIC SURROGATE DERIVED FROM CHECKPOINT JRNL TITL 3 KINASE 1 (CHK1). JRNL REF J. MED. CHEM. V. 60 8945 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 29023112 JRNL DOI 10.1021/ACS.JMEDCHEM.7B01186 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0158 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 3 NUMBER OF REFLECTIONS : 17093 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.178 REMARK 3 R VALUE (WORKING SET) : 0.176 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 919 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.21 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2501 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.14 REMARK 3 BIN R VALUE (WORKING SET) : 0.2600 REMARK 3 BIN FREE R VALUE SET COUNT : 115 REMARK 3 BIN FREE R VALUE : 0.2970 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2078 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 126 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.02 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.64000 REMARK 3 B22 (A**2) : -0.44000 REMARK 3 B33 (A**2) : 2.34000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.11000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.200 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.175 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.145 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.850 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.962 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.939 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2174 ; 0.016 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2026 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2953 ; 1.866 ; 1.986 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4692 ; 1.083 ; 3.008 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 258 ; 6.341 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 99 ;35.597 ;24.343 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 370 ;18.442 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 13 ;14.211 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 318 ; 0.114 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2376 ; 0.009 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 427 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 5OOT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 09-AUG-17. REMARK 100 THE DEPOSITION ID IS D_1200006146. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-MAY-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.92 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.20 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18302 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.090 REMARK 200 RESOLUTION RANGE LOW (A) : 44.282 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.9 REMARK 200 DATA REDUNDANCY : 2.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08000 REMARK 200 FOR THE DATA SET : 7.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.09 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.14 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.80 REMARK 200 R MERGE FOR SHELL (I) : 0.59800 REMARK 200 R SYM FOR SHELL (I) : 0.59800 REMARK 200 FOR SHELL : 1.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 5OOP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.97 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 7% PEG 8000, 0.1 M MES BUFFER PH 6.5, REMARK 280 20% ETHYLENE GLYCOL, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.14000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12730 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 VAL A 3 REMARK 465 LYS A 43 REMARK 465 ARG A 44 REMARK 465 ALA A 45 REMARK 465 VAL A 46 REMARK 465 ASP A 47 REMARK 465 CYS A 48 REMARK 465 PRO A 49 REMARK 465 LYS A 271 REMARK 465 GLY A 272 REMARK 465 ALA A 273 REMARK 465 LYS A 274 REMARK 465 ARG A 275 REMARK 465 PRO A 276 REMARK 465 ARG A 277 REMARK 465 VAL A 278 REMARK 465 THR A 279 REMARK 465 SER A 280 REMARK 465 GLY A 281 REMARK 465 GLY A 282 REMARK 465 VAL A 283 REMARK 465 SER A 284 REMARK 465 GLU A 285 REMARK 465 SER A 286 REMARK 465 PRO A 287 REMARK 465 SER A 288 REMARK 465 GLY A 289 REMARK 465 HIS A 290 REMARK 465 HIS A 291 REMARK 465 HIS A 292 REMARK 465 HIS A 293 REMARK 465 HIS A 294 REMARK 465 HIS A 295 REMARK 465 HIS A 296 REMARK 465 HIS A 297 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE A 5 CG CD1 CD2 CE1 CE2 CZ REMARK 470 TYR A 20 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 MET A 42 CG SD CE REMARK 470 GLU A 50 CG CD OE1 OE2 REMARK 470 LYS A 53 CG CD CE NZ REMARK 470 ARG A 75 CG CD NE CZ NH1 NH2 REMARK 470 ASN A 78 CG OD1 ND2 REMARK 470 LYS A 166 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OAE 4K4 A 301 O HOH A 401 2.10 REMARK 500 SG CYS A 168 O HOH A 511 2.13 REMARK 500 OD1 ASP A 213 NZ LYS A 222 2.18 REMARK 500 NH1 ARG A 162 O HOH A 402 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 7 -116.95 54.77 REMARK 500 GLU A 32 -5.46 78.20 REMARK 500 ASP A 99 -5.63 71.42 REMARK 500 ARG A 129 -4.37 75.66 REMARK 500 ASP A 130 50.35 -144.36 REMARK 500 ASP A 139 -168.02 -77.39 REMARK 500 ASP A 148 100.42 78.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4K4 A 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5OOP RELATED DB: PDB REMARK 900 RELATED ID: 5OOR RELATED DB: PDB DBREF 5OOT A 1 289 UNP O14757 CHK1_HUMAN 1 289 SEQADV 5OOT LEU A 59 UNP O14757 ASN 59 ENGINEERED MUTATION SEQADV 5OOT ILE A 68 UNP O14757 VAL 68 ENGINEERED MUTATION SEQADV 5OOT MET A 84 UNP O14757 LEU 84 ENGINEERED MUTATION SEQADV 5OOT LEU A 86 UNP O14757 TYR 86 ENGINEERED MUTATION SEQADV 5OOT ALA A 87 UNP O14757 CYS 87 ENGINEERED MUTATION SEQADV 5OOT SER A 91 UNP O14757 GLU 91 ENGINEERED MUTATION SEQADV 5OOT HIS A 134 UNP O14757 GLU 134 ENGINEERED MUTATION SEQADV 5OOT ALA A 147 UNP O14757 SER 147 ENGINEERED MUTATION SEQADV 5OOT TYR A 149 UNP O14757 PHE 149 ENGINEERED MUTATION SEQADV 5OOT SER A 150 UNP O14757 GLY 150 ENGINEERED MUTATION SEQADV 5OOT HIS A 290 UNP O14757 EXPRESSION TAG SEQADV 5OOT HIS A 291 UNP O14757 EXPRESSION TAG SEQADV 5OOT HIS A 292 UNP O14757 EXPRESSION TAG SEQADV 5OOT HIS A 293 UNP O14757 EXPRESSION TAG SEQADV 5OOT HIS A 294 UNP O14757 EXPRESSION TAG SEQADV 5OOT HIS A 295 UNP O14757 EXPRESSION TAG SEQADV 5OOT HIS A 296 UNP O14757 EXPRESSION TAG SEQADV 5OOT HIS A 297 UNP O14757 EXPRESSION TAG SEQRES 1 A 297 MET ALA VAL PRO PHE VAL GLU ASP TRP ASP LEU VAL GLN SEQRES 2 A 297 THR LEU GLY GLU GLY ALA TYR GLY GLU VAL GLN LEU ALA SEQRES 3 A 297 VAL ASN ARG VAL THR GLU GLU ALA VAL ALA VAL LYS ILE SEQRES 4 A 297 VAL ASP MET LYS ARG ALA VAL ASP CYS PRO GLU ASN ILE SEQRES 5 A 297 LYS LYS GLU ILE CYS ILE LEU LYS MET LEU ASN HIS GLU SEQRES 6 A 297 ASN VAL ILE LYS PHE TYR GLY HIS ARG ARG GLU GLY ASN SEQRES 7 A 297 ILE GLN TYR LEU PHE MET GLU LEU ALA SER GLY GLY SER SEQRES 8 A 297 LEU PHE ASP ARG ILE GLU PRO ASP ILE GLY MET PRO GLU SEQRES 9 A 297 PRO ASP ALA GLN ARG PHE PHE HIS GLN LEU MET ALA GLY SEQRES 10 A 297 VAL VAL TYR LEU HIS GLY ILE GLY ILE THR HIS ARG ASP SEQRES 11 A 297 ILE LYS PRO HIS ASN LEU LEU LEU ASP GLU ARG ASP ASN SEQRES 12 A 297 LEU LYS ILE ALA ASP TYR SER LEU ALA THR VAL PHE ARG SEQRES 13 A 297 TYR ASN ASN ARG GLU ARG LEU LEU ASN LYS MET CYS GLY SEQRES 14 A 297 THR LEU PRO TYR VAL ALA PRO GLU LEU LEU LYS ARG ARG SEQRES 15 A 297 GLU PHE HIS ALA GLU PRO VAL ASP VAL TRP SER CYS GLY SEQRES 16 A 297 ILE VAL LEU THR ALA MET LEU ALA GLY GLU LEU PRO TRP SEQRES 17 A 297 ASP GLN PRO SER ASP SER CYS GLN GLU TYR SER ASP TRP SEQRES 18 A 297 LYS GLU LYS LYS THR TYR LEU ASN PRO TRP LYS LYS ILE SEQRES 19 A 297 ASP SER ALA PRO LEU ALA LEU LEU HIS LYS ILE LEU VAL SEQRES 20 A 297 GLU ASN PRO SER ALA ARG ILE THR ILE PRO ASP ILE LYS SEQRES 21 A 297 LYS ASP ARG TRP TYR ASN LYS PRO LEU LYS LYS GLY ALA SEQRES 22 A 297 LYS ARG PRO ARG VAL THR SER GLY GLY VAL SER GLU SER SEQRES 23 A 297 PRO SER GLY HIS HIS HIS HIS HIS HIS HIS HIS HET 4K4 A 301 42 HETNAM 4K4 2-[(2-METHOXY-4-{[4-(4-METHYLPIPERAZIN-1-YL)PIPERIDIN- HETNAM 2 4K4 1-YL]CARBONYL}PHENYL)AMINO]-5,11-DIMETHYL-5,11- HETNAM 3 4K4 DIHYDRO-6H-PYRIMIDO[4,5-B][1,4]BENZODIAZEPIN-6-ONE FORMUL 2 4K4 C31 H38 N8 O3 FORMUL 3 HOH *126(H2 O) HELIX 1 AA1 ASN A 51 MET A 61 1 11 HELIX 2 AA2 PHE A 93 ILE A 96 5 4 HELIX 3 AA3 PRO A 103 ILE A 124 1 22 HELIX 4 AA4 LYS A 132 HIS A 134 5 3 HELIX 5 AA5 THR A 170 VAL A 174 5 5 HELIX 6 AA6 ALA A 175 ARG A 181 1 7 HELIX 7 AA7 HIS A 185 GLY A 204 1 20 HELIX 8 AA8 CYS A 215 GLU A 223 1 9 HELIX 9 AA9 PRO A 230 ILE A 234 5 5 HELIX 10 AB1 ASP A 235 LEU A 246 1 12 HELIX 11 AB2 THR A 255 LYS A 260 1 6 SHEET 1 AA1 6 PHE A 5 VAL A 6 0 SHEET 2 AA1 6 TRP A 9 GLY A 16 -1 O TRP A 9 N VAL A 6 SHEET 3 AA1 6 GLU A 22 ASN A 28 -1 O VAL A 23 N LEU A 15 SHEET 4 AA1 6 ALA A 34 ASP A 41 -1 O ILE A 39 N GLU A 22 SHEET 5 AA1 6 ILE A 79 MET A 84 -1 O MET A 84 N ALA A 36 SHEET 6 AA1 6 PHE A 70 GLU A 76 -1 N GLY A 72 O PHE A 83 SHEET 1 AA2 3 GLY A 90 SER A 91 0 SHEET 2 AA2 3 LEU A 136 LEU A 138 -1 O LEU A 138 N GLY A 90 SHEET 3 AA2 3 LEU A 144 ILE A 146 -1 O LYS A 145 N LEU A 137 SHEET 1 AA3 2 ILE A 126 THR A 127 0 SHEET 2 AA3 2 THR A 153 VAL A 154 -1 O THR A 153 N THR A 127 SHEET 1 AA4 2 ARG A 156 TYR A 157 0 SHEET 2 AA4 2 ARG A 160 GLU A 161 -1 O ARG A 160 N TYR A 157 CISPEP 1 ASN A 229 PRO A 230 0 -1.12 SITE 1 AC1 15 GLN A 13 THR A 14 LEU A 15 VAL A 23 SITE 2 AC1 15 MET A 84 GLU A 85 LEU A 86 ALA A 87 SITE 3 AC1 15 SER A 88 HIS A 134 ASN A 135 LEU A 137 SITE 4 AC1 15 ALA A 147 HOH A 401 HOH A 490 CRYST1 45.270 66.280 54.920 90.00 101.99 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022090 0.000000 0.004691 0.00000 SCALE2 0.000000 0.015088 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018614 0.00000